Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;35(7):e23866.
doi: 10.1002/jcla.23866. Epub 2021 Jun 7.

Translation role of circRNAs in cancers

Affiliations
Review

Translation role of circRNAs in cancers

Yaqin Lu et al. J Clin Lab Anal. 2021 Jul.

Abstract

Circular RNAs (circRNAs) constitute a class of covalently closed RNA molecules. With the continuous advancement of high-throughput sequencing technology and bioinformatics tools, many circRNAs have been identified in various human tissues and cell lines. Notably, recent studies have indicated that some circRNAs have translational functions. Internal ribosome entry sites and the N6-methyladenosine modification mediate cap-independent translation. This review describes these two translation mechanisms and verification methods at the molecular level. Databases (including ORF Finder, Pfam, BLASTp, CircRNADb, CircBase, CircPro, CircCode, IRESite, IRESbase) were used to analyze whether circRNAs have the structural characteristic of translation. CircRNA minigene reporter system containing green fluorescent protein (GFP) confirmed the translation potential of circRNAs. Also, we briefly summarize the roles of proteins/peptides encoded by circRNAs (circFBXW7, circFNDC3B, circLgr4, circPPP1R12A, circMAPK1, circβ-catenin, circGprc5a, circ-SHPRH, circPINTexon2, circAKT3) that have been verified thus far in human cancers (triple-negative breast cancer, colon cancer, gastric cancer, hepatocellular carcinoma, bladder cancer, glioblastoma). Those findings suggest circRNAs have a great implication in translation of the human genome.

Keywords: N6-methyladenosine; cancers; circular RNAs; internal ribosome entry sites; translation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
Classification of circRNAs. CircRNAs are divided into circular intronic RNAs (ciRNAs), exonic circRNAs (ecircRNAs), and exon‐intronic circRNAs (EIciRNAs) based on their composition
FIGURE 2
FIGURE 2
CircRNA‐encoded proteins/peptides in human cancers. CC, colon cancer; GC, gastric cancer; HCC, hepatocellular carcinoma; TNBC, triple‐negative breast cancer
FIGURE 3
FIGURE 3
Mechanism of cap‐independent translation initiated by IRES (eg, circFBXW7 in glioblastoma) and by m6A modification in the 5′‐UTR. eIF4G2, eukaryotic translation initiation factor 4 gamma 2; IRES, internal ribosome entry site; m6A, N6‐methyladenosine; METTL14, methyltransferase‐like 14; METTL3, methyltransferase‐like 3; USP28, ubiquitin‐specific peptidase 28; UTR, untranslated region; YTHDC1, YTH domain‐containing 1; YTHDF1, YTH domain family protein 1; YTHDF3, YTH domain family protein 3

References

    1. Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Gen. 2019;20(11):675‐691. - PubMed
    1. Ashwal‐Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre‐mRNA splicing. Mol Cell. 2014;56(1):55‐66. - PubMed
    1. Li Z, Ruan Y, Zhang H, Shen Y, Li T, Xiao B. Tumor‐suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets. Cancer Sci. 2019;110(12):3630‐3638. - PMC - PubMed
    1. Wang Y, Li Z, Xu S, Guo J. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies. J Clin Lab Anal. 2020;34(7):e23359. - PMC - PubMed
    1. Zhang H, Shen Y, Li Z, et al. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. Journal of Clinical Laboratory Analysis. 2020;34(1):e23049. - PMC - PubMed